एपीए उद्धरण

Wang, C., Xu, S., Peng, L., Zhang, B., Zhang, H., Hu, Y., . . . Zhu, W. (2018). Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers. J Enzyme Inhib Med Chem.

शिकागो स्टाइल उद्धरण

Wang, Caolin, Shan Xu, Liang Peng, Bingliang Zhang, Hong Zhang, Yingying Hu, Pengwu Zheng, और Wufu Zhu. "Design, Synthesis and Biological Evaluation of Novel 4-anlinoquinazoline Derivatives As EGFR Inhibitors With the Potential to Inhibit the Gefitinib-resistant Nonsmall Cell Lung Cancers." J Enzyme Inhib Med Chem 2018.

एमएलए उद्धरण

Wang, Caolin, et al. "Design, Synthesis and Biological Evaluation of Novel 4-anlinoquinazoline Derivatives As EGFR Inhibitors With the Potential to Inhibit the Gefitinib-resistant Nonsmall Cell Lung Cancers." J Enzyme Inhib Med Chem 2018.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.